ATTN: As of June 9, our Harbour View office in Suffolk has relocated to 3910 Bridge Road, Ste. 400.

2025 UPDATES: Please bring all new insurance cards to your next appointment and verify your address and phone number when you check in at the front desk.

Clinical Research & Trials

USO 23129

Randomized Study of ONC-392 plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) who Progressed on Androgen Receptor (AR) Pathway Inhibition (PRESERVE-006)

Disease Types: Genitourinary Cancer Research

Available at:

Norfolk (Brock Cancer Center)

Treatment Types

Services

Support During Cancer

Cancers We Treat

Blood Cancers

Blood Disorders

Find a Provider Near You

Clinical Research & Trials

Listen to our podcast

USO 23129

Randomized Study of ONC-392 plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) who Progressed on Androgen Receptor (AR) Pathway Inhibition (PRESERVE-006)